CN101094681A - 透析液及其相关方法和系统 - Google Patents

透析液及其相关方法和系统 Download PDF

Info

Publication number
CN101094681A
CN101094681A CNA2004800390401A CN200480039040A CN101094681A CN 101094681 A CN101094681 A CN 101094681A CN A2004800390401 A CNA2004800390401 A CN A2004800390401A CN 200480039040 A CN200480039040 A CN 200480039040A CN 101094681 A CN101094681 A CN 101094681A
Authority
CN
China
Prior art keywords
type compound
pyrophosphoric acid
acid salt
pyrophosphate
salt type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800390401A
Other languages
English (en)
Chinese (zh)
Inventor
W·查尔斯·欧内尔
科巴·洛马士威尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of CN101094681A publication Critical patent/CN101094681A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA2004800390401A 2003-10-28 2004-10-27 透析液及其相关方法和系统 Pending CN101094681A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51517403P 2003-10-28 2003-10-28
US60/515,174 2003-10-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2012105744771A Division CN103054901A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统

Publications (1)

Publication Number Publication Date
CN101094681A true CN101094681A (zh) 2007-12-26

Family

ID=34572815

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2004800390401A Pending CN101094681A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统
CN2012105744771A Pending CN103054901A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2012105744771A Pending CN103054901A (zh) 2003-10-28 2004-10-27 透析液及其相关方法和系统

Country Status (9)

Country Link
US (1) US20070148258A1 (https=)
EP (1) EP1682077A4 (https=)
JP (1) JP4838139B2 (https=)
KR (1) KR101249707B1 (https=)
CN (2) CN101094681A (https=)
AU (1) AU2004287440A1 (https=)
BR (1) BRPI0416088A (https=)
CA (1) CA2544235C (https=)
WO (1) WO2005044189A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102517635A (zh) * 2012-01-12 2012-06-27 中国科学院新疆理化技术研究所 化合物锂钾磷氧和锂钾磷氧晶体及其制备方法
CN101820889B (zh) * 2007-10-11 2014-03-26 巴克斯特国际公司 包含焦磷酸盐的透析溶液
CN107080752A (zh) * 2010-04-23 2017-08-22 巴克斯特国际公司 减少或防止腹膜透析治疗期间血管钙化的方法和组合物

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187467B2 (en) 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
US8771749B2 (en) 2007-10-05 2014-07-08 National University Corporation Chiba University Stable bicarbonate ion-containing drug solution
ES2332636B1 (es) * 2008-08-06 2011-02-10 Universitat De Les Illes Balears Composicion de liquido de dialisis.
JP5258448B2 (ja) * 2008-08-12 2013-08-07 扶桑薬品工業株式会社 透析用製剤
AU2015200995B2 (en) * 2010-04-23 2016-09-08 Vantive Health Gmbh Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
EP2862583A1 (en) * 2013-10-17 2015-04-22 Gambro Lundia AB Perm selective membrane for treating vascular calcification in chronic hemodialysis patients
DE102015007842A1 (de) * 2015-06-18 2016-12-22 Fresenius Medical Care Deutschland Gmbh Dialyselösung
WO2018165132A1 (en) * 2017-03-06 2018-09-13 University Of Houston System Polyphosphates as inhibitors of calcium crystallization
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
AU2018445164B2 (en) 2018-10-11 2025-05-29 Vifor (International) Ltd. Inositol phosphates for the treatment of ectopic calcification
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN118416279B (zh) * 2024-04-23 2025-09-02 大连医科大学附属第二医院 一种预防血管钙化的动静脉内瘘外用敷料及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE216217T1 (de) * 1996-02-08 2002-05-15 Warner Lambert Co Zahnpflegemittel gegen zahnsteinbildung enthaltend hochlösliche pyrophosphate
US6689275B1 (en) * 1996-12-31 2004-02-10 Ajay Gupta Method and pharmaceutical composition for replacing iron losses in dialysis patients
US6779468B1 (en) * 1997-08-07 2004-08-24 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
DE69734781T2 (de) * 1996-12-31 2006-07-20 Gupta, Ajay, Cerritos Verfahren und pharmazeutische zusammensetzung zum zuführen von eisen bei hämodialyse-und peritonealdialysepatienten
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
JP2002249433A (ja) * 2000-12-19 2002-09-06 Sumitomo Pharmaceut Co Ltd 血管石灰化抑制剤
DK1406641T3 (da) 2001-06-18 2009-05-04 Neptune Technologies & Bioress Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
US6524788B1 (en) * 2001-11-02 2003-02-25 Thomas L. Cantor Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101820889B (zh) * 2007-10-11 2014-03-26 巴克斯特国际公司 包含焦磷酸盐的透析溶液
CN107080752A (zh) * 2010-04-23 2017-08-22 巴克斯特国际公司 减少或防止腹膜透析治疗期间血管钙化的方法和组合物
CN107080752B (zh) * 2010-04-23 2020-07-31 巴克斯特国际公司 减少或防止腹膜透析治疗期间血管钙化的方法和组合物
CN102517635A (zh) * 2012-01-12 2012-06-27 中国科学院新疆理化技术研究所 化合物锂钾磷氧和锂钾磷氧晶体及其制备方法
CN102517635B (zh) * 2012-01-12 2014-12-24 中国科学院新疆理化技术研究所 化合物锂钾磷氧和锂钾磷氧晶体及其制备方法

Also Published As

Publication number Publication date
CA2544235C (en) 2013-12-10
BRPI0416088A (pt) 2007-01-02
KR101249707B1 (ko) 2013-04-05
EP1682077A4 (en) 2009-07-01
KR20070014110A (ko) 2007-01-31
WO2005044189A2 (en) 2005-05-19
CN103054901A (zh) 2013-04-24
JP4838139B2 (ja) 2011-12-14
EP1682077A2 (en) 2006-07-26
WO2005044189A3 (en) 2007-06-14
CA2544235A1 (en) 2005-05-19
AU2004287440A1 (en) 2005-05-19
US20070148258A1 (en) 2007-06-28
JP2007523056A (ja) 2007-08-16

Similar Documents

Publication Publication Date Title
CN101094681A (zh) 透析液及其相关方法和系统
JP2007523056A5 (https=)
AU2014224111B2 (en) Positively charged water-soluble prodrugs of 1H-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates
JP2016512821A (ja) ヘモグロビンの修飾のための組成物及び方法
CA3222841A1 (en) Use of atr inhibitors in combination with parp inhibitors for treating cancer
EA018245B1 (ru) Органические соединения трехвалентного железа фармацевтического качества, их применение и способы их получения
EP3946261A1 (en) Ionic liquids for drug delivery
KR20090094090A (ko) 치료를 위한 방법 및 조성물
CA3172535A1 (en) Cyclophilin inhibitors and uses thereof
KR20210045364A (ko) 악성 림프증식성 장애를 치료하는 방법
CA3113376A1 (en) Compositions for reducing serum uric acid
CN105683152B (zh) 用于治疗高血压和/或纤维化的组合物
AU2022200331A1 (en) Phosphorus prodrugs of sGC stimulators
JP2024175025A (ja) 組織の灌流の増加における使用のためのイノシトールリン酸化合物
EP4313067A1 (en) Treatment of immune-related disorders, kidney disorders, liver disorders, hemolytic disorders, and oxidative stress-associated disorders using nrh, narh and reduced derivatives thereof
US8168596B2 (en) Use of cycloartane compounds for treating arthritis
EP4135696A1 (en) Inhibitors of trpc6 for treating respiratory conditions
KR20130008593A (ko) 상처의 예방 및 치료를 위한 조성물 및 방법
US20060111358A1 (en) Treatment of aml
TW200306811A (en) Medicinal compositions for inhibiting tryptase
RU2358731C2 (ru) Cci-779 для лечения лимфомы из мантийных клеток
MXPA06004730A (en) Dialysates and methods and systems related thereto
TWI853513B (zh) c-Met調控組合物及用於促進肝細胞再生之用途
TW201927307A (zh) 含有１，４－苯并硫氮呯－１－氧化物衍生物之光學異構物之腎功能障礙的改善藥
WO2024036578A1 (en) Methods for preventing or treating h. pylori infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20071226